[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 2016

Innovative Management of Recalcitrant Dissecting Cellulitis With Compression Therapy

Author Affiliations
  • 1Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts
JAMA Dermatol. 2016;152(11):1280-1281. doi:10.1001/jamadermatol.2016.2743

Dissecting cellulitis of the scalp, also known as perifolliculitis capitis abscedens et suffodiens, is a chronic, relapsing, inflammatory disease that often results in scarring alopecia.1 Management of this condition includes medical and sometimes surgical treatments, but disease control can be challenging, and therapies are often ineffective or only temporarily effective.2 Medical therapies include oral isotretinoin, which many consider to be the treatment of choice1,3,4; antiseptics; topical, intralesional, and systemic steroids; topical and oral antibiotics; dapsone; colchicine; oral zinc sulfate; and tumor necrosis factor inhibitors.1-5 Surgical therapies, reserved for only severe, recalcitrant cases, include incision and drainage, local or complete excision with split-thickness skin grafting, laser hair removal, photodynamic therapy, and irradiation.4,5 We report use of an innovative technique in the management of this condition.